These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16169302)

  • 21. Cyclosporine enemas for treatment-resistant, mildly to moderately active, left-sided ulcerative colitis.
    Sandborn WJ; Tremaine WJ; Schroeder KW; Steiner BL; Batts KP; Lawson GM
    Am J Gastroenterol; 1993 May; 88(5):640-5. PubMed ID: 8480724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis.
    Schreiber S; Keshavarzian A; Isaacs KL; Schollenberger J; Guzman JP; Orlandi C; Hanauer SB
    Gastroenterology; 2007 Jan; 132(1):76-86. PubMed ID: 17241861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombophilic abnormalities of natural anticoagulants in patients with ulcerative colitis.
    Zezos P; Papaioannou G; Nikolaidis N; Vasiliadis T; Giouleme O; Evgenidis N
    Hepatogastroenterology; 2007; 54(77):1417-21. PubMed ID: 17708267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis.
    Sandborn WJ; Regula J; Feagan BG; Belousova E; Jojic N; Lukas M; Yacyshyn B; Krzeski P; Yeh CH; Messer CA; Hanauer SB
    Gastroenterology; 2009 Dec; 137(6):1934-43.e1-3. PubMed ID: 19766640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers.
    Shiffman S; Sweeney CT; Ferguson SG; Sembower MA; Gitchell JG
    Clin Ther; 2008 Oct; 30(10):1852-8. PubMed ID: 19014840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of transdermal nicotine on attention and memory in healthy elderly non-smokers.
    Min SK; Moon IW; Ko RW; Shin HS
    Psychopharmacology (Berl); 2001 Dec; 159(1):83-8. PubMed ID: 11797074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study.
    D'Haens G; Hommes D; Engels L; Baert F; van der Waaij L; Connor P; Ramage J; Dewit O; Palmen M; Stephenson D; Joseph R
    Aliment Pharmacol Ther; 2006 Oct; 24(7):1087-97. PubMed ID: 16984503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nicotine: does it have a role in the treatment of ulcerative colitis?
    Slyk MP; Frazee LA
    Am J Ther; 1997 Apr; 4(4):141-8. PubMed ID: 10423604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nicotine therapy for ulcerative colitis: a review of rationale, mechanisms, pharmacology, and clinical results.
    Sandborn WJ
    Am J Gastroenterol; 1999 May; 94(5):1161-71. PubMed ID: 10235187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study.
    Zezos P; Papaioannou G; Nikolaidis N; Patsiaoura K; Papageorgiou A; Vassiliadis T; Giouleme O; Evgenidis N
    Aliment Pharmacol Ther; 2006 May; 23(10):1443-53. PubMed ID: 16669959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial.
    Miner PB; Wedel MK; Xia S; Baker BF
    Aliment Pharmacol Ther; 2006 May; 23(10):1403-13. PubMed ID: 16669955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
    Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
    Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis.
    van Deventer SJ; Wedel MK; Baker BF; Xia S; Chuang E; Miner PB
    Aliment Pharmacol Ther; 2006 May; 23(10):1415-25. PubMed ID: 16669956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of smoking and transdermal nicotine on colonic nicotinic acetylcholine receptors in ulcerative colitis.
    Richardson CE; Morgan JM; Jasani B; Green JT; Rhodes J; Williams GT; Lindstrom J; Wonnacott S; Peel S; Thomas GA
    QJM; 2003 Jan; 96(1):57-65. PubMed ID: 12509650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial.
    Sandborn WJ; Tremaine WJ; Offord KP; Lawson GM; Petersen BT; Batts KP; Croghan IT; Dale LC; Schroeder DR; Hurt RD
    Ann Intern Med; 1997 Mar; 126(5):364-71. PubMed ID: 9054280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis.
    Miner PB; Geary RS; Matson J; Chuang E; Xia S; Baker BF; Wedel MK
    Aliment Pharmacol Ther; 2006 May; 23(10):1427-34. PubMed ID: 16669957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
    Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F
    Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nicotine patch--poor effect in ulcerative colitis. Not sufficiently efficient to justify therapeutic recommendation].
    Nilsson A
    Lakartidningen; 2005 Nov 7-13; 102(45):3281. PubMed ID: 16342541
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical status of ulcerative colitis in patients who smoke.
    Green JT; Rhodes J; Ragunath K; Thomas GA; Williams GT; Mani V; Feyerabend C; Russell MA
    Am J Gastroenterol; 1998 Sep; 93(9):1463-7. PubMed ID: 9732926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Andoh A; Tsujikawa T; Fujiyama Y; Mitsuyama K; Sata M; Yamada M; Iwaoka Y; Kanke K; Hiraishi H; Hirayama K; Arai H; Yoshii S; Uchijima M; Nagata T; Koide Y
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1502-6. PubMed ID: 17101300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.